Welpar Pharmbizz Limited, a active public limited company, was established on 10 May 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2018PLC309197. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹18.50 Cr and a paid-up capital of ₹13.40 Cr.
Employing 22 professional, Its leadership includes Shubham Sanjay Salvi (Director), Manish Paras Chhajed (Director), Kiran Chhajed Paras (Whole-Time Director). Past directors included Shubham Sanjay Salvi, Pallavi Dipesh Chhajed, Kiran Chhajed Paras. It holds ₹8.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 23B,Floor-2,Plot-13,Shree Ram Industrial Estate, 13 G. D. Ambekar Marg, Wadala,, Mumbai, Maharashtra, 400031.
U74999MH2018PLC309197
309197
10 May 2018
₹18.50 Cr
₹13.40 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Welpar Pharmbizz Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shubham Sanjay Salvi | Director | 01 Aug 2018 | Current |
| Manish Paras Chhajed | Director | 10 May 2018 | Current |
| Kiran Chhajed Paras | Whole-Time Director | 10 May 2018 | Current |
| Dipesh Paras Chhajed | Managing Director | 10 May 2018 | Current |
| Aakash Hinger | Director | 01 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Dec 2018 | Past |
| Pramod Abcsdd | Director | 09 Dec 2019 | Past |
| Pramod Abcsdd | Director | 01 Jun 2018 | Past |
| Pramod Abcsdd | Director | 01 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Welpar Pharmbizz Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 37.39% decrease. The company also saw a substantial fall in profitability, with a 342.69% decrease in profit. The company's net worth dipped by a decrease of 9.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Welpar Pharmbizz had a promoter holding of 66.23% and a public holding of 33.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2019 | Others | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Welpar Pharmbizz has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Welpar Pharmbizz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welpar Pharmbizz's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Welpar Pharmbizz Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Welpar Pharmbizz Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100233687 was registered on 04 Jan 2019. was completed.
The activity Shubham Sanjay Salvi was appointed as a Director was appointed as a Director on 01 Aug 2018 & has been associated with this company since 7 years 4 months . was completed.
Aakash Hinger was appointed as a Director was appointed as a Director on 01 Aug 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Manish Paras Chhajed was appointed as a CFO was appointed as a CFO on 10 May 2018 & has been associated with this company since 7 years 7 months . was documented.
The CIN of Welpar Pharmbizz Limited is U74999MH2018PLC309197.
Welpar Pharmbizz Limited is headquartered at 23B,Floor-2,Plot-13,Shree Ram Industrial Estate, 13 G. D. Ambekar Marg, Wadala,, Mumbai, Maharashtra, 400031.
Welpar Pharmbizz Limited was incorporated on 10 May 2018.
The current directors of Welpar Pharmbizz Limited are
The primary industry of Welpar Pharmbizz Limited is Trade.
Welpar Pharmbizz Limited is unlisted.
The authorized capital of Welpar Pharmbizz Limited is ₹18.50 Cr, and the paid-up capital is ₹13.40 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX